Teleflex Reports Q4 Earnings, Outlines Portfolio Transition

Company to divest Acute Care, Interventional Urology, and OEM businesses, focus on high-growth hospital products

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Teleflex (NYSE:TFX) reported its Q4 2025 earnings and outlined a major portfolio transition, including plans to divest its Acute Care, Interventional Urology, and OEM businesses. The company will create a more focused 'RemainCo' and integrate its recently acquired BIOTRONIK Vascular Intervention business. Teleflex also provided a 2026 outlook shaped by separation-related costs, with plans to use divestiture proceeds to return capital to shareholders and reduce debt.

Why it matters

Teleflex's strategic shift reflects broader trends in the medical device industry, as companies look to streamline their portfolios and focus on higher-growth, higher-margin product lines. The divestments and integration of BIOTRONIK will position Teleflex to compete more effectively in the acute care and hospital settings, where it sees significant opportunities for growth.

The details

Teleflex will divest its Acute Care, Interventional Urology, and OEM businesses, creating a more focused 'RemainCo' that will be led by a new CEO. The company plans to use divestiture proceeds to return capital to shareholders and reduce debt. Teleflex also discussed the integration of its recently acquired BIOTRONIK Vascular Intervention business, increased R&D investment expectations, and a 2026 outlook shaped by separation-related stranded costs.

  • Teleflex reported its Q4 2025 earnings on March 3, 2026.
  • The company's interim CEO, Stuart Randle, stepped into the role in January 2026 following the board's decision to transition the CEO position.

The players

Teleflex Incorporated

A diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals.

Stuart Randle

Interim President and CEO of Teleflex, who stepped into the role in January 2026 following the board's decision to transition the CEO position.

John Deren

Chief Financial Officer of Teleflex.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.